
Crown Bioscience
Crown Bioscience is a global contract research organization providing discovery, preclinical and translational platforms and services to advance oncology and immuno-oncology. They are known for their high-quality and expansive in vivo, in vitro, and ex vivo preclinical models, and partner with their clients to quantify the efficacy and pharmacological profile of their drug candidate(s) before they move into the clinic. Crown Bioscience aims to deliver superior drug candidates to ensure that patients get the right treatment at the right time.
Latest Crown Bioscience Content

Pan-cancer Assay-ready Organoid Drug Screening With Robust, Reproducible, and Clinically-relevant Output

MS-based Proteomics: 4D-DIA Proteomics & 4D Phosphoproteomics
This will allow clients to assess the biological function of proteins for understanding signaling mechanisms within cells as well as specific biomarkers to diseases, and systematically assess quantitative differences in protein profiles of distinct samples for biomedical and clinical research.

Quantitative Proteomics Services To Upgrade Your Research

An Introduction to Organoids, Organoid Creation, Culture and Applications

High-Throughput and High-Content Screening in Organoids and 3D Models With Michiel Fokkelman
